Yes the whole issue of open access to scientific research has been in the news a lot recently. For example, not so long ago Elsevier took legal action against the Sci-Hub website for providing access to what Elsevier regarded as its corporate property. Elsevier's publishing model is arguably one of the most profitable (and some would say predatory) in the world, and it will be interesting to see what will be the long term impact of sites such as Sci-Hub, which for most scientists in developing (and developed!) nations is the first port of call in looking up papers now.
- Forums
- ASX - By Stock
- NEU
- Ann: Presentations and publication for Rett syndrome trials
NEU
neuren pharmaceuticals limited
Add to My Watchlist
0.00%
!
$16.48

Ann: Presentations and publication for Rett syndrome trials, page-4
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$16.48 |
Change
0.000(0.00%) |
Mkt cap ! $2.076B |
Open | High | Low | Value | Volume |
$16.48 | $16.77 | $16.28 | $3.108M | 188.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 105 | $16.48 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$16.54 | 885 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 105 | 16.480 |
1 | 1996 | 16.430 |
1 | 1454 | 16.400 |
3 | 2043 | 16.380 |
1 | 2500 | 16.370 |
Price($) | Vol. | No. |
---|---|---|
16.540 | 885 | 2 |
16.550 | 2037 | 2 |
16.610 | 2000 | 1 |
16.640 | 60 | 1 |
16.690 | 225 | 1 |
Last trade - 16.13pm 28/07/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |